Connect with us

Business

Morison opens largest pharma manufacturing facility in Sri Lanka

Published

on

Morison PLC, the largest oral solid dosage pharmaceutical manufacturer in Sri Lanka and a subsidiary of Hemas Holdings PLC, ceremonially opened their new state-of-the-art manufacturing plant and research & development facility in the presence of Prime Minister Mahinda Rajapaksa yesterday.

Several Cabinet ministers and dignitaries also graced the event as special guests, including Minister of Health Pavithra Wanniarachchi; State Minister of Production, Supply and Regulation of Pharmaceuticals, Prof. Channa Jayasumana; State Minister of Skills Development, Vocational Education, Research and Innovation Minister Dr. Seetha Arambepola and Secretary to Minister of Trade Dr. Sunil Navaratne. Located within the Sri Lanka Nano Technology Park in Pitipana, Homagama this is the second manufacturing facility of Morison PLC. The factory is ready to commence validation batches and is expected to start commercial production early next year, supporting the government’s aim to manufacture essential medicines locally.

Morison is committed to increase access of high quality, affordable medicines to all Sri Lankans and enables it with the new plant, with a capacity to supply over 20% of Sri Lanka’s tablet needs. A pioneer in the local manufacture of pharmaceuticals, Morison’s new facility with an investment of USD 18.5 million reaches a major milestone in Sri Lanka, being the first European Union-Good Manufacturing Practice (EU-GMP) compliant oral solid dosage manufacturing plant in Sri Lanka.

Speaking at the ceremony, Murtaza Esufally, Managing Director, Morison PLC said, “The launch of the new state-of the-art manufacturing facility marks a new era for Morison PLC, continuing our 80-year long mission to offer the highest quality products at affordable prices. This investment is supported through the guaranteed buy-back agreements that will help us to build economies of scale and be more competitive in global markets. Continued government support will enable us create a stronger footprint in exports and begin contract manufacture partnerships with global pharma companies, helping Sri Lanka earn valuable foreign exchange as we look to the future.”

 

GMP compliance requires that medicines are of consistent high quality and are appropriate for their intended use. EU GMP is an essential requirement to be a credible pharmaceutical manufacturer and exporter to global, regulated markets.

“We at Morison continue to look forward to delivering the highest quality products by partnering with global pharmaceutical leaders, with whom Hemas is privileged to have strong, legacy relationships. We will explore this new phase of growth in conformance with global protocols and regulations, through the formulation of new products and the development of opportunities in new markets”, Esufally continued. “Our partnership with SLINTEC will advance our strides in formulation research through the deployment of nano and advanced technology” he added.

Morison produces 75 different formulations of medicine and intends to grow that portfolio in the coming years to address Sri Lanka’s growing medicinal needs, especially in the sphere of non-communicable diseases. Its new plant has an annual production capacity of 5 billion tablets and 10 million bottles of medicine working at peak capacity on double shift, and aims to improve employment opportunities with the creation of 250 skilled jobs. The strength of the factory lies not only in its manufacturing capabilities. It also lies in its ability to create more skilled jobs and uplift the Homagama community through exposure of pharmaceutical sciences to the schools in the area and by working with higher educational institutions for internships and joint research.

The new plant is designed for minimum human intervention to prevent human error and includes cutting edge equipment such as the fully automated liquid manufacturing and packing lines, fully-fledged chemical and microbiology labs, separate air handling units to control environment conditions ­and is a also equipped with Enterprise Resource Planning software. The plant also has the first zero liquid discharge waste water systems in the country.

Business

realme dares to leap into Sri Lankan youth market with cutting edge devices

Published

on

realme, the world’s fastest-growing smartphone brand, launched its products in Sri Lanka on the November 23. The virtual launch event took place with the participation of Chanux bro and realme Sri Lanka team where benchmark, trendsetting realme products were introduced to the Sri Lankan market.

The launch expands the reach of the fastest smartphone brand to reach 50 million product sales worldwide, to a brand new market with young users looking for the very best in technology and smart devices. Ranked among the Top 5 brands in over 13 markets globally in just two years of operation, realme is ranked seventh globally. Proclaiming it will ‘dare to leap’, realme identifies with young people who are willing to take a risk, and has launched four cutting edge products to the Sri Lanka market, set to exceed expectations.

realme 7 – sharper captures and cooler gaming with faster charges

realme 7 grabs the imagination of the youth with a 64MP Quad Camera with Sony IMX682 sensor for sharper captures, the World’s First MediaTek Helio G95 Gaming Processor for cool gaming and a 30W Dart Charge, taking just 26 mins to get 5000mAh battery 50% Charged. The sleek smartphone comes with a 6.5-inch 90Hz Ultra Smooth Display with a 16MP In-display Selfie Camera and Starry Mode.

The first smartphone to have passed TÜV Rheinland Smartphone Reliability, realme 7 is the first in segment smartphone with the Sony 64MP Quad Camera.

Continue Reading

Business

President to inaugurate CCC Sri Lanka Economic Summit

Published

on

Sri Lanka’s foremost economic summit will be inaugurated by Chief Guest Gotabaya Rajapaksa, President of the Democratic Socialist Republic of Sri Lanka on December 1. The summit is themed “Roadmap for Take-off: Driving a People Centric Economic Revival”. The President will also deliver the inaugural address.

Mahinda Rajapaksa, Prime Minister of the Democratic Socialist Republic of Sri Lanka, will launch the second phase of the summit on December 2 and participate in the VVIP session focused on “Empowering Take-off: Efficient Government and Progressive State Enterprises.”

The Inaugural session on December 1, commencing at 8.30am will feature addresses by keynote speaker Nirmala Sitharaman, Minister of Finance and Corporate Affairs of the Republic of India and Guest of Honour Ajith Nivard Cabraal, State Minister of Money and Capital Markets and State Enterprise Reforms. Dr. Hans Wijayasuriya – chairman of the Ceylon Chamber of Commerce will deliver the welcome address.

The flagship summit will be held on a virtual format in compliance with health guidelines and will bring together key policymakers, business leaders as well as the input of top international thought leaders will come together to identify the steps in developing the pathway towards the accelerated and people centric revival of the country’s economy.

Participants may register for the entire two-day virtual summit, or pick the sessions of their choice, an opportunity offered for the first time. Registrations for the event are now open. For further information, please contact Niroshini on niroshini@chamber.lk or 0115588852; or Alikie on alikie@chamber.lk or 0115588805. (CCC)

 

 

Continue Reading

Business

Central Bank’s policy rates decision to be driven by two options

Published

on

by Sanath Nanayakkare

The Central Bank will be reviewing its monetary policy stance on November 26. In this context, First Capital Research has put forward strong arguments both for and against an interest rate cut, in its Pre-Policy Analysis.

Making their argument against further relaxation in monetary policy First Capital said, “As a response to the measures taken by the government, private sector credit has improved to Rs. 87.4Bn in September while market liquidity reached Rs. 140 bn by 13th Nov indicating that there is surplus liquidity in the system. Moreover, the unemployment rate, which was at 5.7% in the 1Q2020 has declined to 5.4% in the second quarter. These indicators suggest that economic activity has remained steady without much deterioration in the 2Q. Except the GDP growth numbers, where the 2Q2020 figures are yet to be seen, other indicators are signifying a recovery, inquiring the need of further policy easing at the upcoming review”.

“In response to previous monetary easing measures implemented by CBSL, to bring down costs of borrowing of businesses and households, both market deposit and lending rates adjusted notably so far during the year. AWPR declined to historic lows in recent weeks, while banks’ lending rates also witnessed a downward adjustment in line with CBSL’s expectations. We believe that considering the recovery in the private credit and historic low levels in AWPR, there is no vital requirement for CBSL to provide a rate cut and to further bring down the market lending rates drastically”.

Their arguments for further relaxation in monetary policy was: “A thrust for development is the need of the current government. We estimate that Sri Lanka’s GDP would see its steepest contraction in history of -5.8% in 2020 following the unexpected contraction in 1Q GDP growth of -1.6% while 2Q GDP figures are yet to be seen. However, the government’s key drive is the development oriented economic growth which was spelt out through the budget 2021 as well. Accordingly, the government plans to reach 6% and above GDP growth during the next 5 years commencing from 2021. As we believe, a development-oriented budget coupled with further low interest rate environment can support the government’s medium-term goals. Therefore, the need to accelerate the GDP growth can be considered as a major factor favouring further policy easing at the upcoming review.”

Continue Reading

Trending